Related Experiment Video

Updated: Mar 10, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

906

Could advanced drug delivery systems be the future in cardiovascular revascularization medicine?

Marco Zuin1,2, Gianluca Rigatelli3, Giuseppe Faggian4

  • 11 Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara, Italy.

Vascular
|December 9, 2016
PubMed

Insights

Nanotechnology offers promising solutions for cardiovascular revascularization, addressing limitations of traditional thrombolytic treatments for conditions like myocardial infarction and stroke. These advancements aim to improve blood flow restoration while minimizing bleeding risks.

Area of Science:

  • Cardiovascular Medicine
  • Nanotechnology Applications
  • Interventional Cardiology

Background:

  • Prompt revascularization is critical for acute myocardial infarction, stroke, and pulmonary embolism to restore blood flow.
  • Fibrinolytic therapy is declining for myocardial infarction due to percutaneous coronary intervention advancements.
  • Systemic thrombolysis remains vital for ischemic stroke and pulmonary embolism but faces contraindications and bleeding risks.

Purpose of the Study:

  • To explore the emerging role of nanotechnology in cardiovascular revascularization.
  • To discuss recent findings and potential future clinical implications of nanomedicine in treating cardiovascular emergencies.

Main Methods:

  • Review of recent advancements in nanotechnology for cardiovascular applications.
  • Analysis of how nanotechnology can overcome limitations of current thrombolytic agents.
  • Discussion of potential nanotechnological approaches for targeted drug delivery and improved revascularization.

Main Results:

  • Nanotechnology presents innovative strategies to enhance the efficacy of cardiovascular revascularization.
  • Emerging nanomedical solutions show potential to mitigate bleeding complications associated with thrombolysis.
  • Recent findings highlight nanotechnology's capacity to improve targeted delivery and therapeutic outcomes in cardiovascular emergencies.

Conclusions:

  • Nanotechnology holds significant promise for revolutionizing cardiovascular revascularization therapies.
  • Future clinical practice may see widespread adoption of nanomedicine to improve treatment of acute cardiovascular events.
  • Continued research in nanocardiology is essential to fully realize the potential of these advanced therapeutic approaches.

Keywords:
Revascularisationnanoparticlesthrombolytic therapy

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

12.8K

Related Concept Videos

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
84
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
130
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
82
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
86